BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

441 related articles for article (PubMed ID: 17499464)

  • 1. Surgical treatment versus concurrent chemoradiotherapy as an initial treatment modality in advanced olfactory neuroblastoma.
    Kim HJ; Kim CH; Lee BJ; Chung YS; Kim JK; Choi YS; Yoon JH
    Auris Nasus Larynx; 2007 Dec; 34(4):493-8. PubMed ID: 17499464
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Esthesioneuroblastoma treated with non-craniofacial resection surgery followed by combined chemotherapy and radiotherapy: An alternative approach in limited resources.
    Rastogi M; Bhatt M; Chufal K; Srivastava M; Pant M; Srivastava K; Mehrotra S
    Jpn J Clin Oncol; 2006 Oct; 36(10):613-9. PubMed ID: 16926225
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Results of salvage therapy after failure of initial treatment for advanced olfactory neuroblastoma.
    Kim HJ; Cho HJ; Kim KS; Lee HS; Kim HJ; Jung E; Yoon JH
    J Craniomaxillofac Surg; 2008 Jan; 36(1):47-52. PubMed ID: 18312791
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Clinical analysis of 53 cases of esthesioneuroblastoma].
    Chen YF; Yang AK; Zhang Q; Ouyang D; Chen WK; Chen FJ
    Ai Zheng; 2009 Mar; 28(3):308-11. PubMed ID: 19619448
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Long-term experiences in the therapy of esthesioneuroblastoma].
    Koch M; Constantinidis J; Dimmler A; Strauss C; Iro H
    Laryngorhinootologie; 2006 Oct; 85(10):723-30. PubMed ID: 16673299
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Olfactory neuroblastoma: past, present, and future?
    Lund VJ; Howard D; Wei W; Spittle M
    Laryngoscope; 2003 Mar; 113(3):502-7. PubMed ID: 12616204
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Esthesioneuroblastoma in childhood and adolescence. Better prognosis with multimodal treatment?
    Eich HT; Müller RP; Micke O; Kocher M; Berthold F; Hero B
    Strahlenther Onkol; 2005 Jun; 181(6):378-84. PubMed ID: 15925980
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Prognostic factors and outcome of esthesioneuroblastoma].
    Zhao LJ; Gao L; Xu GZ; Li SY; Xiao GL
    Zhonghua Zhong Liu Za Zhi; 2005 Sep; 27(9):561-4. PubMed ID: 16438858
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Radiation therapy for esthesioneuroblastoma: rationale for elective neck irradiation.
    Monroe AT; Hinerman RW; Amdur RJ; Morris CG; Mendenhall WM
    Head Neck; 2003 Jul; 25(7):529-34. PubMed ID: 12808655
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Esthesioneuroblastoma: continued follow-up of a single institution's experience.
    Loy AH; Reibel JF; Read PW; Thomas CY; Newman SA; Jane JA; Levine PA
    Arch Otolaryngol Head Neck Surg; 2006 Feb; 132(2):134-8. PubMed ID: 16490869
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multimodality therapy including radiotherapy and chemotherapy improves event-free survival in stage C esthesioneuroblastoma.
    Eich HT; Hero B; Staar S; Micke O; Seegenschmiedt H; Mattke A; Berthold F; Müller RP
    Strahlenther Onkol; 2003 Apr; 179(4):233-40. PubMed ID: 12707712
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Radiotherapy for esthesioneuroblastoma: is elective nodal irradiation warranted in the multimodality treatment approach?
    Noh OK; Lee SW; Yoon SM; Kim SB; Kim SY; Kim CJ; Jo KJ; Choi EK; Song SY; Kim JH; Ahn SD
    Int J Radiat Oncol Biol Phys; 2011 Feb; 79(2):443-9. PubMed ID: 20421144
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Olfactory neuroblastoma: 15 years of experience.
    Kondo N; Takahashi H; Nii Y; Nagao J
    Anticancer Res; 2012 May; 32(5):1697-703. PubMed ID: 22593448
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Olfactory neuroblastoma: results of combined therapy.
    Tandon DA; Bahadur S; Mohanti BK; Rath GK
    Indian J Cancer; 1994 Jun; 31(2):124-9. PubMed ID: 7927445
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intensity-modulated radiotherapy with concurrent chemotherapy for previously irradiated, recurrent head and neck cancer.
    Biagioli MC; Harvey M; Roman E; Raez LE; Wolfson AH; Mutyala S; Han HS; Markoe A
    Int J Radiat Oncol Biol Phys; 2007 Nov; 69(4):1067-73. PubMed ID: 17967302
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Olfactory neuroblastoma: the University of Erlangen-Nuremberg experience 1975-2000.
    Constantinidis J; Steinhart H; Koch M; Buchfelder M; Schaenzer A; Weidenbecher M; Iro H
    Otolaryngol Head Neck Surg; 2004 May; 130(5):567-74. PubMed ID: 15138422
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The results of combined treatment patients with olfactory neuroblastoma in material of Cancer Center in Warsaw].
    Jarząbski A; Kiprian D; Szutkowski Z; Kawecki A; Michalski W
    Otolaryngol Pol; 2011 Sep; 65(5 Suppl):93-7. PubMed ID: 22000257
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combined modality therapy of esthesioneuroblastoma.
    McLean JN; Nunley SR; Klass C; Moore C; Müller S; Johnstone PA
    Otolaryngol Head Neck Surg; 2007 Jun; 136(6):998-1002. PubMed ID: 17547995
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Multidrug chemotherapy in a 8-year old child with advanced olfactory neuroblastoma].
    Cwiklińska M; Balwierz W; Armata J; Załeska-Czepko E
    Pediatr Pol; 1995 Nov; 70(11):981-3. PubMed ID: 8677167
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Esthesioneuroblastoma: is there a need for elective neck treatment?
    Demiroz C; Gutfeld O; Aboziada M; Brown D; Marentette LJ; Eisbruch A
    Int J Radiat Oncol Biol Phys; 2011 Nov; 81(4):e255-61. PubMed ID: 21676553
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.